Clinical Needs of Patients with Problem Drug Use
- PMID: 26355132
- PMCID: PMC4883106
- DOI: 10.3122/jabfm.2015.05.150004
Clinical Needs of Patients with Problem Drug Use
Abstract
Introduction: Illicit drug use is a serious public health problem associated with significant co-occurring medical disorders, mental disorders, and social problems. Yet most individuals with drug use disorders have never been treated, though they often seek medical treatment in primary care. The purpose of this study was to examine the baseline characteristics of people presenting in primary care with a range of problem drug use severity to identify their clinical needs.
Methods: We examined sociodemographic characteristics, medical and psychiatric comorbidities, drug use severity, social and legal problems, and service utilization for 868 patients with drug problems. These patients were recruited from primary care clinics in a medical safety net setting. Based on Drug Abuse Screening Test results, individuals were categorized as having low, intermediate, or substantial/severe drug use severity.
Results: Patients with substantial/severe drug use severity had serious drug use (opiates, stimulants, sedatives, intravenous drugs); high levels of homelessness (50%), psychiatric comorbidity (69%), and arrests for serious crimes (24%); and frequent use of expensive emergency department and inpatient hospitals. Patients with low drug use severity were primarily users of marijuana, with little reported use of other drugs, less psychiatric comorbidity, and more stable lifestyles. Patients with intermediate drug use severity fell in between the substantial/severe and low drug use severity subgroups on most variables.
Conclusions: Patients with the highest drug use severity are likely to require specialized psychiatric and substance abuse care, in addition to ongoing medical care that is equipped to address the consequences of severe/substantial drug use, including intravenous drug use. Because of their milder symptoms, patients with low drug use severity may benefit from a collaborative care model that integrates psychiatric and substance abuse care in the primary care setting. Patients with intermediate drug use severity may benefit from selective application of interventions suggested for patients with the highest and lowest drug use severity. Primary care safety net clinics are in a key position to serve patients with problem drug use by developing a range of responses that are locally effective and that may also inform national efforts to establish patient-centered medical homes and to implement the Affordable Care Act.
Keywords: Comorbidity; Delivery of Health Care; Drug Abuse; Health Care Costs; Integrated; Primary Health Care.
© Copyright 2015 by the American Board of Family Medicine.
Conflict of interest statement
Similar articles
-
Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.JAMA. 2014 Aug 6;312(5):492-501. doi: 10.1001/jama.2014.7860. JAMA. 2014. PMID: 25096689 Free PMC article. Clinical Trial.
-
Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use.Am J Psychiatry. 2004 Aug;161(8):1455-62. doi: 10.1176/appi.ajp.161.8.1455. Am J Psychiatry. 2004. PMID: 15285973 Clinical Trial.
-
Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.J Gen Intern Med. 2003 Jan;18(1):1-8. doi: 10.1046/j.1525-1497.2003.10601.x. J Gen Intern Med. 2003. PMID: 12534757 Free PMC article.
-
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.Health Technol Assess. 2001;5(21):1-75. doi: 10.3310/hta5210. Health Technol Assess. 2001. PMID: 11532238 Review.
-
Integration of mental health/substance abuse and primary care.Evid Rep Technol Assess (Full Rep). 2008 Nov;(173):1-362. Evid Rep Technol Assess (Full Rep). 2008. PMID: 19408966 Free PMC article. Review.
Cited by
-
Barriers and facilitators to primary care engagement for people who inject drugs: A systematic review.J Nurs Scholarsh. 2023 May;55(3):605-622. doi: 10.1111/jnu.12863. Epub 2022 Dec 8. J Nurs Scholarsh. 2023. PMID: 36480158 Free PMC article.
-
Facilitators and Barriers to Health Seeking among People Who Use Drugs in the Sunyani Municipality of Ghana: An Exploratory Study.Biomed Res Int. 2021 Aug 21;2021:2868953. doi: 10.1155/2021/2868953. eCollection 2021. Biomed Res Int. 2021. PMID: 34471636 Free PMC article.
-
Treatment Needs of Patients With Severe Alcohol Use Disorders.Indian J Psychol Med. 2024 Aug 28:02537176241276151. doi: 10.1177/02537176241276151. Online ahead of print. Indian J Psychol Med. 2024. PMID: 39564247 Free PMC article.
-
Comparative analysis of methods for identifying multimorbidity patterns among people with opioid use disorder: A retrospective single-cohort study.PLoS One. 2025 Jun 12;20(6):e0324548. doi: 10.1371/journal.pone.0324548. eCollection 2025. PLoS One. 2025. PMID: 40505080 Free PMC article.
-
Evaluating Connections Between Polysubstance Use, Social Drivers of Health, and Mental Health Symptoms in People With HIV.Open Forum Infect Dis. 2025 Apr 24;12(4):ofaf172. doi: 10.1093/ofid/ofaf172. eCollection 2025 Apr. Open Forum Infect Dis. 2025. PMID: 40290561 Free PMC article.
References
-
- US Department of Justice. The Economic Impact of Illicit Drug Use on American Society. Washington, DC: 2011.
-
- Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry. 2007;64(5):566–576. - PubMed
-
- Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch. Intern. Med. 2003;163(20):2511–2517. - PubMed
-
- Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511–2518. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources